NIH intends to sole-source Oxford Nanopore PromethION 2 sequencer.
Some language patterns suggest this RFP may be written for a specific incumbent vendor. Review qualification requirements and brand-specific terms carefully before committing bid resources.
The National Institutes of Health (NIH) intends to award a sole-source contract to Oxford Nanopore Technologies for a PromethION 2 Integrated Instrument. This instrument is used for real-time DNA/RNA sequencing and is required for ongoing research at the NIH. The notice indicates that the government believes only one responsible source can meet the requirement, suggesting a tailored procurement. No other details on scope, duration, or value are provided.